Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
45,885
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,241
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
1 Diseases matching "Advanced Solid Tumor"
🏥 Disease / Health Topic
Advanced solid tumors
11
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT02520752
A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors
Completed · Phase 1
NCT02626234
A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors
Completed · Phase 1
NCT00793897
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors
Completed · Phase 1
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Advanced solid tumors
🏥 Names
Disease Name
Advanced solid tumors
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Advanced solid tumors
topic type
disease
tcmsp disease id
32
📋 Clinical Trials
11 · subject of clinical studyNCT02520752 A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine i
→ cMET-dysregulated Advanced Solid Tumors
NCT02626234 A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharma
→ cMET-dysregulated Advanced Solid Tumors
NCT00793897 Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in
→ Advanced Solid Tumors|Metastatic Solid Tumors
NCT01235897 MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressin
→ Advanced Solid Tumors|Tumors|Cancer
NCT01285466 A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without
→ Metastatic or Locally Advanced Solid Tumors
NCT01293630 A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carbopl
→ Advanced Solid Tumors
NCT01491204 Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety
→ Advanced Solid Tumors
NCT01494688 A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Partic
→ Advanced Solid Tumors
NCT01992341 AMG 386 Drug-Drug Interaction Study With Paclitaxel
→ Advanced Solid Tumors
NCT04492033 A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Adva
→ P1b: Advanced Solid Tumors|P2: Biliary Tract Cance
NCT01596647 Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients Wi
→ Advanced Solid Tumors, Excluding Breast Cancer
How to read these connections
Each box lists records connected to the one you are viewing, and says how the connection was made. A connection shows that two records are related in the source data. It does not show that something works, is safe or should be used, and a record with many connections is not necessarily better studied or more effective.
- Study records (trials, systematic reviews, publications): the study names this subject. Registered or ongoing studies have no results here, and animal or cell research does not show an effect in people.
- Source-database links (for example herb and compound, compound and gene target): taken from the imported databases and not independently checked by us.
- Name matches (for example formula and herb, or a condition named in a study): found by matching names, so they can be wrong. Treat them as leads, not findings.